BPCE
PCVX icon

Bank Pictet & Cie (Europe)’s Vaxcyte PCVX Stock Holding History

Bank Pictet & Cie (Europe)’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-3,363
Closed -$275K – 200
2024
Q4 		$275K Sell
3,363
-442
-12% -$43.9K 0.01% 151
2024
Q3 		$435K Sell
3,805
-89
-2% -$8.02K 0.01% 122
2024
Q2 		$294K Sell
3,894
-952
-20% -$64.8K 0.01% 138
2024
Q1 		$331K Buy
+4,846
New +$336K 0.01% 146

Other funds holding PCVX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Bank Pictet & Cie (Europe)'s PCVX Position: Q1 2025 in Review

Bank Pictet & Cie (Europe) sold out of Vaxcyte (PCVX) in Q1 2025, closing a stake of 3,363 shares — an estimated $275K sold.

Bank Pictet & Cie (Europe) first reported a position in PCVX in Q1 2024 and held it in 4 quarters. The position peaked at $435K in Q3 2024. 315 funds tracked by Wall St. Rank hold PCVX as of Q1 2025.

  • Bank Pictet & Cie (Europe) reported no remaining Vaxcyte position as of Q1 2025 after selling out during the quarter.
  • Bank Pictet & Cie (Europe) sold 3,363 Vaxcyte shares in Q1 2025, an estimated $275K.
  • Bank Pictet & Cie (Europe) first reported a position in Vaxcyte in Q1 2024 and held it in 4 quarters.
  • Bank Pictet & Cie (Europe)'s Vaxcyte position peaked at $435K in Q3 2024.
  • 315 funds tracked by Wall St. Rank held Vaxcyte as of Q1 2025.

Based on Bank Pictet & Cie (Europe)'s 13F filing for Q1 2025, filed 17 Apr 2025.